home / stock / hbp:cc / hbp:cc news

HBP:CC News and Press, Helix BioPharma Corp. From 03/15/23

Stock Information
Company Name: Helix BioPharma Corp.
Stock Symbol: HBP:CC
Market: TSXC
Menu
HBP:CC HBP:CC Quote HBP:CC Short HBP:CC News HBP:CC Articles HBP:CC Message Board
Get HBP:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
HBP:CC - Helix Biopharma Corp. Announces Fiscal 2023 Second Quarter Results

(TheNewswire) Toronto, O N - TheNewswire - March 15, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of im...
HBP:CC - Helix Biopharma Corp. Reports Voting Results

(TheNewswire) Toronto, Ontario – TheNewswire – January 24, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on it...

HBP:CC - Helix Biopharma Corp. Announces Grant & Cancellation of Stock Options

(TheNewswire) Toronto, O N - TheNewswire - January 9, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based ...

HBP:CC - Helix BioPharma Corp. Announces Fiscal 2023 First Quarter Results

(TheNewswire) Toronto, Ontario – Thenewswire – December 14, 2022 – Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in ...
HBP:CC - Helix Biopharma Corp. Announces Board & Management Changes

(TheNewswire) Toronto, O N – TheNewswire - December 8, 2022 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its pro...

HBP:CC - Helix Biopharma Corp. Closes Private Placement of CAD $4.62 Million

(TheNewswire) NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario – TheNewswire – November 3, 2022 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “...

HBP:CC - HELIX BIOPHARMA CORP. Announces Fiscal 2022 Year-End Results

(TheNewswire) Toronto, Ontario – TheNewswire – November 1, 2022 - Helix BioPharma Corp. (TSX:HBP), (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the fi...
HBP:CC - Helix BioPharma Corp. Appoints Dr. Frank Gary Renshaw as Chief Medical Officer

(TheNewswire) October 3, 2022 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp . (TSX:HBP) (OTC:HBPCF) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapie...

HBP:CC - Helix Biopharma Corp. Appoints Gabrielle M Siegers as the Head of Research & Development

(TheNewswire) Toronto, Ontario – TheNewswire – September 1, 2022 – Helix BioPharma Corp . (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the fi...

HBP:CC - Helix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LP

(TheNewswire) Toronto, Ontario – TheNewswire – August 30, 2022 – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the field of ...
Previous 10 Next 10